A peer-reviewed article published in JACC: Advances has validated that a risk prediction algorithm incorporating HeartBeam's credit card-sized ECG device can accurately identify heart attack risk in patients presenting with chest pain. The study, which evaluated 184 patients, found that the algorithm achieved an area under the curve (AUC) of 86.5% using a single HeartBeam ECG reading combined with patient risk factors and symptoms. The AUC rose to 92.9% when a personal, symptom-free baseline ECG was available for comparison. AUC is a measure of a test's ability to distinguish between those with and without a condition, with 100% being perfect.
HeartBeam (NASDAQ: BEAT) is a medical technology company focused on transforming cardiac care. The company said the results support heart attack detection as a future indication for the HeartBeam System and advance its broader clinical program. The HeartBeam System is a cable-free device capable of collecting ECG signals in 3D from three non-coplanar directions and synthesizing the signals into a 12-lead ECG. This platform technology is designed for portable devices that can be used wherever the patient is to deliver actionable heart intelligence.
HeartBeam’s 3D ECG technology received FDA clearance for arrhythmia assessment in December 2024 and the 12-lead ECG synthesis software in December 2025, as noted on the company's cleared indications for use page. The company holds over 20 issued patents related to technology enablement.
The study's implications are significant for emergency medicine, where rapid and accurate identification of heart attacks is critical. Currently, standard ECG machines are often bulky and limited to clinical settings. A portable device that can provide accurate risk assessment could enable earlier detection and treatment, potentially improving outcomes for patients with chest pain.
Physicians using the HeartBeam technology will be able to identify cardiac health trends and acute conditions and direct patients to the appropriate care—all outside of a medical facility, thus redefining the future of cardiac health management. The latest news and updates relating to BEAT are available in the company’s newsroom at https://ibn.fm/BEAT.
